Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Viral Hepatitis
In what scenario do you screen patients with hepatitis B for hepatitis D co-infection?
Answer from: at Academic Institution
I routinely screen every patient once at an initial diagnosis of chronic hepatitis B.
Sign In
or
Register
to read more
29102
Related Questions
What clinical scenario do you consider screening for hepatitis delta?
Should an individual who received the purified protein Hepatitis B vaccine in 1985 receive a booster or have antibody titers checked?
What role is there for the assessment of hepatitis B virus genotype as it pertains to pharmacologic therapy and HCC screening?
When would you consider quantification of hepatitis B surface antigen as part of the treatment decision making process?
In what scenarios do you defer treatment of a patient's hepatitis C if they are undergoing liver transplant evaluation?
All things being equal, what patient factors are you looking at in the selection of TAF or TDF in the management of hepatitis B?
Pending final results, but in what scenario would you select bepirovirsen as opposed to established therapy for hepatitis B patients (ex: TAF or TDF)? Is an attempt for functional cure the goal for all patients?
How do you approach the surveillance and serologic evaluation of a patient in whom you suspect has a hepatitis B pre-core mutant?
When would you consider quantification of hepatitis B surface antigen as part of the treatment decision making process?
In patients with hepatitis B and co-infection with hepatitis D, given their increased risk of development of HCC, how do you approach screening for this?